NIH

Key TakeawaysTen new studies from the NIH’s Human Tumor Atlas Network (HTAN) reveal how tumors evolve, spread, and respond to treatments. These findings...

Key TakeawaysResearchers discovered that mutant RAS proteins promote tumor growth through a newly identified mechanism beyond cell surface signaling. This finding may lead...

In a pivotal move for the Parkinson's community, AbbVie has secured FDA approval for VYALEV™, a groundbreaking subcutaneous 24-hour infusion treatment designed for adults...

Johnson & Johnson continues to blaze a trail in the field of neuroscience, reinforcing its commitment to addressing complex mental health challenges through innovation....

GSK has unveiled groundbreaking data on its Arexvy vaccine, offering hope for expanding protection against respiratory syncytial virus (RSV) to a wider demographic. This...

In a significant step forward for heart failure management, Boston Scientific has revealed that the HeartLogic Heart Failure Diagnostic has received endorsement from the...

A recent groundbreaking study has highlighted significant advancements in treating diabetic macular edema (DME) for African American, Black, Hispanic, and Latino populations. Conducted by...

The U.S. Food and Drug Administration (FDA) has been actively addressing various health and safety concerns, showcasing a dynamic week of developments and decisions....

The National Institutes of Health (NIH) embarks on an innovative journey with its latest clinical trial, myeloMATCH, set to redefine treatment paradigms for patients...

In the realm of chronic kidney diseases, IgA nephropathy stands as a particularly challenging condition, often progressing to end-stage kidney disease despite current treatment...

In a world where access to healthcare remains a privilege rather than a right, Stryker and Operation Smile have embarked on a commendable journey...

Key TakeawaysLeniolisib's effectiveness in PIDs with immune dysregulation is under evaluation. The clinical trial targets rare disorders with substantial unmet medical needs. NIH...

Key Takeaways - The orphan drug status ensures seven years of market exclusivity for opaganib upon FDA approval. - Opaganib's mechanism of action targets multiple cellular...

The RADx Tech ACT ENDO Challenge, led by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National...

A significant advancement in the fight against cancer has emerged with the development of a novel artificial intelligence (AI) tool designed to predict patient...